Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
"Management credibility is strained, the brand appears to be weakening and the company is selling a distant strategic vision while the core business deteriorates," Benchmark analyst Mike Hickey said
Takano Y, Iwano S, Aoki S, et al
Starting July 1, 2026, Medicare will cover FDA-approved weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) for a flat $50 per month through a new initiative called the Medicare GLP-1 Bridge Program
Tirzepatide is the active ingredient in Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved specifically for chronic weight management) both manufactured by Eli Lilly
US$ 26.86
US$ 23.91
US$ 22.61
US$ 26.12
US$ 27.00
US$ 25.33
US$ 22.54
